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Aim: In stress research, reducing times of stress induction may contribute to improving the well-being of experimental animals, 
especially in cancer models, already under physiological distress. To support this idea, we evaluated the effects of a short-timed 
stress protocol on endocrine, metabolic and immune indicators in mice bearing the L5178Y-R lymphoma. Materials and Methods: 
A 30-minute daily stress protocol was applied for 28 days to healthy and lymphoma-bearing BALB/c mice; body weight, plasma 
levels of corticosterone, norepinephrine, Th1/Th2 cytokines, insulin, and leptin, were measured. Results: We found a 12% significant 
decrease in body weight in non-tumor bearing mice under stress (p < 0.007). The disruption of weight evolution was accompanied 
by a stress induced 85% decrease in plasmatic leptin (p < 0.01) and total reduction of insulin. Tumor burden alone was associated 
to an increase in more than two-fold of plasmatic levels of norepinephrine (p < 0.008). Neither stress nor tumor or their combina-
tion, resulted in an elevation of systemic IL-6. IFN-γ levels were 20 times higher in lymphoma-bearing animals when compared 
with non-tumor bearing mice (p < 0.01); however, under stress, this response was reduced by half, indicating a suppressing effect 
of chronic stress on the antitumor immune response. Conclusion: A short-timed stress induction is enough to cause significant altera-
tions in the metabolism and immunity of healthy and tumor-bearing mice, supporting the use of short-timed protocols as an efficient 
way to induce chronic stress that also considers concerns regarding the well-being of experimental animals in biomedical research.
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Psychogenic stress has been proven to have a signifi-
cant role in cancer initiation and progression; hence, the 
study of its many biological effects is of great inte rest [1, 
2]. Besides providing a rational basis for preventive 
stress management, such studies may identify targets 
for therapeutic intervention aiming at improving quality 
of life in cancer patients. In this sense, an often used 
pre-clinical approach to study the influence of stress 
on cancer involves the application of a stress-inducing 
paradigm in tumor-bearing animals [3]. One of the most 
frequently used is the restraint stress paradigm, which 
involves placing mice or rats in a small, closed container 
to reduce its ability to move [4, 5]. Other paradigms, 
such as forced swim and social isolation are also valuable 
to dissect the mechanisms behind the biological effects 
of psychogenic stress [6, 7].
These stress-inducing paradigms must be able 
to induce the activation of the hypothalamic-pituitary-
adrenal (HPA) axis through the secretion of cortisol, 
and/or the sympathetic adrenal medullary (SMA) axis 
with the release of noradrenaline; both hormones 
physiological markers of stress [5]. More recently, the 
IL6-STAT3 axis has been revealed as a pathway also in-
volved in mediating the effects of psychogenic stress, 
where systemic IL-6 elevation has been associated 
with stressful conditions [8], with the potential to affect 
a diverse array of cellular and molecular targets [9]. 
Other markers of chronic stress activation also include 
body weight fluctuations and changes in behavior, 
including depression and feeding behavior [10]. In-
terestingly, cancer, as a form of physiological stress, 
can also elicit these same responses [11].
In the context of the increasing concern regarding ani-
mal well-being in biomedical research, for psychogenic 
stress research, the induction of stress makes necessary 
to cause a certain level of discomfort in experimental 
animals, but how much and for how long is not a settled 
matter, although efforts have been made to optimize 
times of induction and parameters [12]. For chronic 
stress induced by restriction of movement, we have 
found that a significant number of studies employ the 
restraint paradigm for periods ranging from 2 to 6 h [4]. 
Previously, Zamora-González [13] had demonstrated 
that a daily protocol of 30 min of restraint stress, that 
also includes the aleatory use of the forced swim test, 
as a stress inductor, and resting days to avoid habitua-
tion in animals, is enough for the activation of the HPA 
axis in BALB/c mice. In this work, we applied this short-
timed stress inducing protocol to test its ability to elicit 
a chronic stress response in the L5178Y-R mouse model 
of lymphoma, with the aim of establishing an effective 
mouse model to study cancer initiation and progression 
under psychogenic stress and that is also compliant with 
animal welfare concerns regarding the use of experimen-
tal animals in biomedical research.
MATERIAL AND METHODS
Animals. Female, 10–12-week-old BALB/c mice 
were purchased from Harlan Laboratories S.A. de C.V. 
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(México City, Mexico) and were housed in an ani-
mal care facility at 24–26 °C with 45% humidity and 
a 12 h light: 12 h dark cycle, in individually ventilated 
cages with environment enrichment; water and food 
were provided ad libitum. All procedures performed 
in animals followed ethical standards on animal welfare 
and were approved by the Institutional Animal Care and 
Use Committee (CICUAL-LIV).
L5178Y-R lymphoma model. To test the influ-
ence of a chronic stress paradigm on tumor bearing 
animals we used the L5178Y-R lymphoma mouse 
model. This lymphoma is maintained in ascites form 
in BALB/c mice by the intraperitoneal transplantation 
of 1•106 L5178Y-R cells per mouse. Thirteen days 
after inoculation, ascites is collected from the perito-
neal cavity of mice killed by cervical dislocation under 
anesthesia. The cell suspension is then washed twice 
in PBS by centrifuging at 2000 rpm for 10 min, finally 
adjusting to 2•107 cells/ml in sterile PBS. To induce the 
formation of a solid tumor, 0.1 ml of the cell suspension 
was inoculated in the right flank of mice by intramus-
cular injection [14].
Chronic stress protocol. Animals were randomly 
distributed into 4 experimental groups (n = 4): non-tumor 
bearing animals in resting conditions (a) and under 
stress (b); and lymphoma-bearing animals in resting 
conditions (c) and under stress (d). Animals in resting 
conditions remained in their cages while the stress ses-
sions were carried on. Experimental mice were subjected 
to a 28 days chronic stress protocol consisting in two 
stress paradigms [13]: restraint stress (30 min) and forced 
swim (15 min); these were randomly applied from day 0, 
as shown in Fig. 1. For restraint stress, the animals were 
placed in 50 ml conical tubes with ventilation holes. A sec-
ond, larger container was employed for tumor-bearing 
animals once tumor size made difficult to contain the ani-
mals in the conical tubes. For the forced swim test, a plastic 
cylindrical tank, 19 cm height by 15 cm diameter, was 
employed; the container was filled up to 8.5 cm from the 
bottom with tap water, temperature was set at 25 °C. Mice, 
one at a time, were carefully placed in the water under 
constant vigilance, and after 15 min, were removed and 
gently dried before being returned to the cage.
On day 4, mice were inoculated with the 
L5178Y-R lymphoma, as previously described. On days 
9, 16 and 23 the anhedonia test was performed. Body 
weight was measured every 4 days. At the end of the 
protocol, blood was collected by cardiac puncture 
of mice under anesthesia, after which animals were 
euthanized by cervical dislocation and tumor and liver 
samples were collected and stored frozen. Blood was 
centrifuged at 5000 rpm, and plasma was collected 
and stored at −80 °C until analysis.
Anhedonia test. To assess behavioral disrup-
tions caused by the stress protocol, animals were 
subjected to the sucrose preference test, also known 
as anhedonia test. This test measures the animal’s pre-
ference for sweetened drinks, a reward, over plain 
water, as an indicator of the ability to feel pleasure. 
The test was carried out in the housing cages, two 
drink bottles per cage, one containing 200 ml of tap 
water, and the other the same volume of a 2% sucrose 
solution (Jalmek Científica, S.A. de C.V.) were made 
available to the animals for 48 h. Water and sucrose 
solution intake were measured at 24 and 48 h. Su-
crose preference was calculated as the percentage 
of sucrose solution intake over total fluid intake [15]. 
Before testing, the animals were habituated to having 
the 2 bottles, water and sucrose solution, over a 3 day 
period, switching the position of the bottles every 
24 h [16], to avoid potential bias due to the rejection 
of a new item by the animals.
Cytokines and hormones. Plasma levels of IL-2, 
IL-4, IL-6, IFN-γ, TNF, IL-17A, and IL-10 were deter-
mined in an Accuri 6 flow cytometer using the Cy-
tometric Bead Array Mouse Th1/Th2/Th17 kit from 
BD Biosciences (San Jose, CA), data was analyzed 
with the FCAP Array Software V 3.0 (Soft Flow Hungary, 
Ltd., Pécs, Hungary). Plasma levels of corticosterone 
and norepinephrine were measured with the Corticos-
terone EIA Kit from Enzo Life Sciences (NY, USA) and 
the Mouse Noradrenaline ELISA kit from MyBiosource 
(San Diego, California), respectively. Insulin and leptin 
were measured in a MAGPIX® system using the Mouse 
Metabolic Magnetic Bead Panel from Merck Millipore.
Statistical analysis. Level of significance was as-
sessed by Student’s t test. Statistical analyses were per-
formed by using the website for statistical computation 
VassarStats, freely available at http://vassarstats.net/.
RESULTS
We subjected non-tumor bearing and lymphoma-
bearing mice to a short-timed stress paradigm for 
28 days (Fig. 1); we found that this chronic short stress 
induction was sufficient to significantly alter some key, 
but not all, immunological and metabolic parameters 
evaluated. Despite being brief, the stress protocol 
interfered with weight gain in non-tumor and lymphoma-
bearing mice. In Fig. 2, the weight progression of ex-
perimental animals during the experiment is shown. 
By the end of the protocol, at day 28th, non-bearing 
tumor animals in resting conditions showed a 9% mean 
increment of their weight, meanwhile, stressed mice 
not only failed to gain weight, at day 28 their mean 
weight was 3% lower than on day 0 of the experiment 
(p < 0.007). For lymphoma-bearing mice, weight gain 
in stressed animals was half of those resting (16%), 
here; the increasing weight displayed by lymphoma-
bearing animals must be attributed to tumor growth, 
having the unintended effect of masking weight loss 
by the animals.
Tumor progression
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Fig. 1. Stress protocol timeline. Female BALB/c mice, 
11 week-old at the beginning of the experiment, were subjected 
to a chronic stress protocol combining the restraint and forced 
swim paradigms for 28 days. Control animals were kept undis-
turbed in their cages. RE — restraint stress; FS — forced swim; 
R — resting; T — tumor inoculation; AT — anhedonia test; S — 
mice sacrifice and sample collecting
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Fig. 2. Body weight evolution under chronic stress. Body 
weight was measured every 3 days. Weight gain is expressed 
as a percentage of the weigh at the beginning of the experiment. 
Data represent mean ± SEM of 4 animals from a representative 
experiment. *p < 0.05 as compared with the respective control
To evaluate the effect of chronic stress on the 
L5178Y-R model, the anhedonia test was performed 
twice during the experiment; for 48 h, animals were 
offered the choice between two bottles, one containing 
tap water and the other a 2% sucrose solution, a de-
crease in sucrose solution intake would be indicative 
of depression in the animals, however, no differences 
were detected among the experimental groups, find-
ing sucrose preference across the groups ranging 
from 76–81%, above the 65% used as criterion for 
anhedonia [16].
To test the activation of the HPA and adrenergic 
system, the plasmatic levels of corticosterone and 
norepinephrine were measured using ELISA. Accord-
ing to the results, the short induction of stress used 
in this study failed to activate the HPA system, levels 
of corticosterone remained unchanged between the 
experimental groups (Table). As for the adrenergic 
system, although norepinephrine levels were unaf-
fected by stress, a 240% increase was observed for 
resting lymphoma-bearing animals when compared 
to resting non-tumor bearing animals (p < 0.008), 
suggesting that tumor burden, but not the stress 
protocol tested, activates the sympathetic system 
in BALB/c mice (Table).
Table. Neuroendocrine responses of female BALB/c mice to chronic stress
Mice Groups Corticosterone, pg/ml Norepinephrine, pg/ml
Non-tumor Resting 111.5 ± 8.7 131.3 ± 34.6
Stress 124.5 ± 4.7 163.8 ± 118.0
Tumor Resting 120.3 ± 6.1 315.2 ± 88.2
Stress 138.5 ± 6.8 262.8 ± 78.0
Plasma levels of Th1, Th2 and Th17 cytokines 
were also evaluated. Here, we found that although 
IL-4, IL-2 and TNF were detected (concentration 
ranging from 8.5–10 pg/ml), no differences were 
observed among the experimental groups. Unex-
pectedly, IL-6 was not detected in any experimen-
tal group. Then, according to the results, anti and 
pro-inflammatory cytokines were mostly unaffected 
by the short time of stress protocol tested, with one 
important exception, levels of IFN-γ were significantly 
elevated in lymphoma-bearing mice (40.06 ± 9 pg/ml) 
when compared to non-bearing tumor animals, how-
ever lymphoma-bearing animals under chronic stress 
showed 50% lower levels of plasmatic IFN-γ (p < 0.05) 
(Fig. 3).
Non-tumor bearing animals showed a reduction 
of 95.8% in levels of plasmatic leptin in animals under 
stress (p < 0.01). In lymphoma-bearing animals, le-
vels of leptin were also lower when compared to non-
tumor bearing animals, regardless of stress induction 
(Fig. 4). Although insulin was detected in non-tumor 
bearing animals (236 ± 160 pg/ml), it was not detected 
in non-tumor bearing animals under stress, or in rest-
ing or stressed lymphoma-bearing mice.
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Fig. 3. Plasmatic levels of IFN-γ in BALB/c mice under chronic 
stress. At day 28, animals were anesthetized with ketamine/
xylazine and whole blood was collected by terminal cardiac 
puncture, sample collection was performed between 16:00 and 
20:00 hours. Levels of IFN-γ were measured by flow cytometry 
using a cytometric bead array. Data represent mean ± SEM 
of 4 animals from a representative experiment. *p < 0.05, 
**p < 0.01 as compared with the respective control
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Fig. 4. Plasmatic levels of leptin in BALB/c mice under chronic 
stress. At day 28, animals were anesthetized with ketamine/
xylazine and whole blood was collected by terminal car-
diac puncture, sample collection was performed between 
16:00 and 20:00 hours. Levels of leptin were measured by mul-
tiplexed immunoassay in a MAGPIX® system. Data represent 
mean ± SEM of 4 animals from a representative experiment. 
**p < 0.01 as compared with the respective control
DISCUSSION
In this work, with the aim of establishing a refined 
model to measure the effects of psychogenic stress 
in cancer, considering the welfare of experimental ani-
mals, we measured the effects of a short-timed chronic 
stress protocol in mice bearing the L5178Y-R lympho-
ma. We found that although not all parameters were 
affected, some were distinctly altered by the stress 
protocol; with some of the observed changes suggest-
ing a disruption in the ability to maintain body weight 
that is potentially being driven by adrenergic activation. 
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Body weight is a useful and inexpensive parameter 
to assess the effect of stress on living beings under 
various conditions. In this work, under stress, the body 
weight of non-tumor bearing animals was significantly 
lower than in resting non-tumor bearing mice, this dis-
ruption could also be observed in lymphoma-bearing 
mice. Weight loss is an indication of a compromised 
energy metabolism in the animals, it can also be the 
result of behavioral changes, such as decreasing 
food intake, however we have no data to support this 
hypothesis and the results of the anhedonia test (data 
not shown) do not suggest that this short-timed stress 
induction paradigm is enough to change the behavior 
of animals.
The sustained activation of both the HPA axis 
and adrenergic pathways during chronic stress may 
trigger adaptive thermogenesis with the mobiliza-
tion of the body energy stores leading to weight loss. 
Under stress, changes in feeding behavior could also 
be involved in weight loss. These changes may be at-
tributed to HPA activation, however, according to our 
results, the protocol tested was not able to activate the 
HPA axis; levels of corticosterone were not different 
between resting and stressed animals. This contradicts 
the findings of Zamora-González et al. [13] since they 
reported the elevation of corticosterone in animals 
subjected to the same stress protocol. Given that they 
used mice of the same strain, sex, and age, these 
contradicting results may be explained by the time 
of the day the sample was collected. Overall, there 
is ample controversy regarding HPA axis activation 
as an indicator of stress induction, since a signifi-
cant number of studies have failed to find alterations 
in corticosterone levels in animals under restraint and 
social stress [17].
Another potential contributor to weight loss is the 
elevation of peripheral IL-6, a pro-inflammatory cy-
tokine that has been linked to the induction of un-
coupling-1 protein leading to brown tissue activation 
and weight loss [18], however, as previously stated 
in the results section, this cytokine was mostly absent 
in plasma in experimental animals, regardless of treat-
ment. As for adrenergic activation, lymphoma-bearing 
animals showed elevated plasma levels of norepi-
nephrine, and although non-tumor bearing animals 
under stress also showed an elevation when compared 
to resting animals, it was not statistically significant. 
Weight decrease in non-tumor bearing animals under 
stress, may be in part due to adrenergic activation.
The analysis of plasmatic levels of leptin and in-
sulin supports the view of a disrupted metabolism 
in the animals, caused not only by stress but also 
by tumor burden, that may be involved in weight 
maintenance. In non-tumor bearing animals under 
stress, levels of leptin were significantly lower, 95.8%, 
than in resting animals. Levels of leptin were not dif-
ferent in L5178Y-R lymphoma-bearing mice under 
stress when compared with resting animals. It could 
be expected that changes in levels of leptin, a satiety 
messenger, to be accompanied by changes in food 
intake behavior, playing a role in weight maintenance, 
something that needs to be assessed. Insulin was ab-
sent in non-tumor bearing animals under stress, and 
in lymphoma-bearing mice, under resting and stress 
conditions as well.
In regard to IFN-γ, it was evident that tumor burden 
causes an elevation in plasmatic IFN-γ in the animals; 
this change is consistent with an antitumoral response 
mounted by the host. However, such a response 
was reduced in lymphoma-bearing mice subjected 
to stress by half. Previously, it has been demonstrated 
that acute and chronic stress by restraint or immo-
bilization induces a decrease in INF-γ plasma levels 
in rats [19, 20] and in a mouse model of contact hyper-
sensitivity also [21]. This effect has also been observed 
in pre-clinical models of cancer, where decreasing 
IFN-γ expression contributes to tumor progression 
in mouse models of lymphoma, colorectal cancer and 
melanoma [22–24]. In these studies, the daily protocol 
for stress induction ranged from 2 to 4 h when restraint 
or immobilization was used, some other authors used 
psychosocial paradigms for up to 24 h, whereas in the 
present study, 30 min of daily stress were sufficient 
to find a significant effect after 28 days. The relevancy 
of IFN-γ suppression by stress during cancer progres-
sion should not be underestimated; however, recent 
findings shed light on a potential additional target 
of this stress-induced immune dysfunction, since it has 
been shown that IFN-γ supports social behavior and 
neuronal connectivity [25]. Moreover, in mice knock-
out for IFN-γ, attenuation of the neuroendocrine and 
immune responses to chronic stress and disturbed 
spatial recognition memory in the basal state have 
been observed [26, 27]. These studies suggest a role 
for IFN-γ in mediating stress responses.
In conclusion, our results show that the daily induc-
tion in non-tumor and lymphoma bearing BALB/c mice 
of 30 min of restraint stress, with intercalated days 
of forced swim and days to rest, disrupts metabolism 
as shown by decreased weight, leptin, and insulin, this 
despite an absence of HPA axis activation or increasing 
IL-6 levels in plasma, with the potential involvement 
of adrenergic activation according to norepinephrine 
plasma levels. The protocol was also able to suppress 
the IFN-γ response of lymphoma-bearing animals, 
a dysfunction that many studies show to be relevant 
to understand the relationships between neuroen-
docrine and immune parameters during health and 
disease.
ACKNOWLEDGMENTS
We are grateful to the Laboratory of Immunology 
and Virology, FCB, UANL for their support for this 
study. This work was also supported by grant CN362-
15 04 from Programa de Investigación Científica y Tec-
nológica (PAICYT), Universidad Autónoma de Nuevo 
León (UANL), México to DCH.
DISCLOSURE
The authors have no conflicts of interest to disclose.
280 Experimental Oncology 39, 276–280, 2017 (December)
REFERENCES
1. Cao L, During MJ. What is the brain-cancer connec-
tion? Annu Rev Neurosci 2012; 35: 331–45.
2. Shin JK, Lee JY, Yang RY, et al. Molecular mechanisms 
underlying psychological stress and cancer. Curr Pharm Des 
2016; 22: 2389–402.
3. Xie H, Li C, He Y, et al. Chronic stress promotes oral 
cancer growth and angiogenesis with increased circulating 
catecholamine and glucocorticoid levels in a mouse model. 
Oral Oncol 2015; 51: 991–7.
4. Buynitsky T, Mostofsky DI. Restraint stress in biobe-
havioral research: recent developments. Neurosci Biobehav 
Rev 2009; 33: 1089–98.
5. Bali A, Jaggi AS. Preclinical experimental stress stu-
dies: protocols, assessment and comparison. Eur J Pharmacol 
2015; 746: 282–92.
6. Jaggi AS, Bhatia N, Kumar N, et al. A review on animal 
models for screening potential anti-stress agents. Neurol Sci 
2011; 32: 993–1005.
7. Petit-Demouliere B, Chenu F, Bourin M. Forced 
swimming test in mice: a review of antidepressant activity. 
Psychopharmacology 2005; 177: 245–55.
8. Rohleder N, Aringer M, Boentert M. Role of interleu-
kin-6 in stress, sleep, and fatigue. Ann N Y Acad Sci 2012; 
1261: 88–96.
9. Tanaka T, Kishimoto T. Targeting interleukin-6: all 
the way to treat autoimmune and inflammatory diseases. Int 
J Biol Sci 2012; 8:1227.
10. Allen AP, Kennedy PJ, Cryan JF, et al. Biological and 
psychological markers of stress in humans: focus on the Trier 
Social Stress Test. Neurosci Biobehav Rev 2014; 38: 94–124.
11. Lee JH, Yoo SB, Kim NY, et al. Interleukin-6 and the 
hypothalamic-pituitary-adrenal activation in a tumor bearing 
mouse. Int J Neurosci 2008; 118: 355–64.
12. Kim KS, Han PL. Optimization of chronic stress 
paradigms using anxiety- and depression-like behavioral 
parameters. J Neurosci Res 2006; 83: 497–507.
13. Zamora-González EO, Santerre A, Palomera-
Avalos V, et al. A chronic combinatory stress model that acti-
vates the HPA axis and avoids habituation in BALB/C mice. 
J Neurosci Methods 2013; 213: 70.
14. Gomez-Flores R, Caballero-Hernandez D, Tamez-
Guerra R, et al. Increased survival of tumor-bearing mice 
by the delta opioid SNC 80. Anticancer Res 2005; 25: 4563–7.
15. Chiba S, Numakawa T, Ninomiya M, et al. Chronic 
restraint stress causes anxiety- and depression-like behaviors, 
downregulates glucocorticoid receptor expression, and attenu-
ates glutamate release induced by brain-derived neurotrophic 
factor in the prefrontal cortex. Prog Neuropsychopharmacol 
Biol Psychiatry 2012; 39: 112–9.
16. Strekalova T, Spanagel R, Bartsch D, et al. Stress-
induced anhedonia in mice is associated with deficits in forced 
swimming and exploration. Neuropsychopharmacology 2004; 
29: 2007–17.
17. Otovic P, Hutchinson E. Limits to using HPA axis acti-
vity as an indication of animal welfare. Altex 2015; 32: 41–50.
18. Li G, Klein RL, Matheny M, et al. Induction of un-
coupling protein 1 by central interleukin-6 gene delivery is de-
pendent on sympathetic innervation of brown adipose tissue 
and underlies one mechanism of body weight reduction in rats. 
Neuroscience 2002; 115: 879–89.
19. Himmerich H, Fischer J, Bauer K, et al. Stress-induced 
cytokine changes in rats. Eur Cytokine Netw 2013; 24: 97–103.
20. Kalinichenko LS, Koplik EV, Pertsov SS. Cytokine 
profile of peripheral blood in rats with various behavioral 
characteristics during acute emotional stress. Bull Exp Biol 
Med 2014; 156: 441.
21. Hall JM, Witter AR, Racine RR, et al. Chronic psy-
chological stress suppresses contact hypersensitivity: Potential 
roles of dysregulated cell trafficking and decreased IFN-γ pro-
duction. Brain Behav Immun 2014; 36: 156–64.
22. Frick LR, Barreiro Arcos ML, Rapanelli M, et al. 
Chronic restraint stress impairs T-cell immunity and promotes 
tumor progression in mice. Stress 2009; 12: 134–43.
23. Peters S, Grunwald N, Rümmele P, et al. Chronic 
psychosocial stress increases the risk for inflammation-related 
colon carcinogenesis in male mice. Stress 2012; 15: 403–15.
24. Sommershof A, Scheuermann L, Koerner J, et al. 
Chronic stress suppresses anti-tumor T CD8+ responses 
and tumor regression following cancer immunotherapy 
in a mouse model of melanoma. Brain Behav Immun 2017; 
65: 140–9.
25. Filiano AJ, Xu Y, Tustison NJ, et al. Unexpected role 
of interferon-γ in regulating neuronal connectivity and social 
behaviour. Nature 2016; 535: 425–9.
26. Litteljohn D, Cummings A, Brennan A, et al. Interfer-
on-gamma deficiency modifies the effects of a chronic stressor 
in mice: implications for psychological pathology. Brain Behav 
Immun 2010; 24: 462–73.
27. Litteljohn D, Nelson E, Hayley S. IFN-γ differentially 
modulates memory-related processes under basal and chronic 
stressor conditions. Front Cell Neurosci 2014; 8: 391.
Copyright © Experimental Oncology, 2017
